PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1346578-3	1992	One patient with a CD19+/CD5+/CD25- phenotype and one with a pentostatin-treated CD19+/CD25- variant form had minor responses.	Pentostatin	61-72	interleukin 2 receptor subunit alpha	Homo sapiens	87-91	
2303314-3	1990	Recently, we and others have demonstrated that in cells rendered ADA deficient by treatment with deoxycoformycin, dAdo affects T-cell activation events which precede DNA synthesis, such as interleukin 2 receptor (IL-2R) expression and IL-2 production.	Pentostatin	97-112	interleukin 2 receptor subunit alpha	Homo sapiens	189-211	
2303314-3	1990	Recently, we and others have demonstrated that in cells rendered ADA deficient by treatment with deoxycoformycin, dAdo affects T-cell activation events which precede DNA synthesis, such as interleukin 2 receptor (IL-2R) expression and IL-2 production.	Pentostatin	97-112	interleukin 2 receptor subunit alpha	Homo sapiens	213-218	
12061204-1	2002	The high therapeutic efficiency of lymphotoxic purine analogues, pentostatin and cladribine in hairy cell leukaemia which express the antigen CD25 (alpha chain interleukin-2 receptor) suggests the hypothesis whether protracted cellular immunodeficiency after treatment does not represent an important mechanism of control of this specific lymphoproliferation.	Pentostatin	65-76	interleukin 2 receptor subunit alpha	Homo sapiens	142-146